Literature DB >> 8396567

A novel human monoclonal antibody directed to a tumor-associated antigen.

T Kudo1, S Kobayashi, K Murakami, R Takano, M Nose, N Sato, H Saeki, S Saijyo, S Hiyamuta, A Kadota.   

Abstract

Twelve human monoclonal antibodies (HuMAb) were established by the fusion of (mouse x human) heteromyeloma cells with B-lymphoblastoid cells derived from the regional lymph nodes of three patients with squamous cell carcinoma of the lung. They were tested for reactivity to two kinds of proteins (purified protein derivatives and bovine serum albumin) by ELISA, Sq-19 (squamous cell carcinoma) culture cells by indirect membrane immunofluorescence tests, and Sq-19 tumor xenograft by immunohistological study. Among them, one HuMAb 904F (IgM, lambda) was selected. In indirect membrane immunofluorescence tests, this 904F antibody reacted with various kinds of cell lines, e.g. lung cancer, esophageal cancer, endometrial cancer, and stomach cancer. It did not react with malignant hematopoietic and diploid fibroblast cell lines. Immunohistologically, it stained the tumor nests of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung. It also stained those of esophagus and colon, but not those of small cell carcinoma of lung, or stomach. On frozen-section specimens of normal tissues from various organs, it showed only limited areas of positive staining. Limited positive findings were observed at a reticular zone of the adrenal gland, at the esophagus as weak staining, and at islets of the pancreas as very weak staining. Western blotting analysis demonstrated that it recognized a 54 kDa trypsin-sensitive molecule which is expressed on the surface of tumor cells. These results suggest the 904F monoclonal antibody detects a novel tumor-associated antigen which is recognized by the human immune system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396567      PMCID: PMC5919199          DOI: 10.1111/j.1349-7006.1993.tb02041.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


sheep red blood cell enzyme‐linked immunosorbent assay bovine serum albumin horseradish peroxidase sodium dodecyl sulfate polyacrylamide gel electrophoresis hypoxanthine, aminopterine and thymidine purified protein derivatives dimethylsulfoxide lymphoblastoid cell line fetal bovine surum Epstein‐Barr virus indirect membrane immunofluorescence phosphate‐buffered saline periodate‐lysine‐paraformaldehyde
  36 in total

1.  Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes.

Authors:  L H Smith; A Yin; M Bieber; N N Teng
Journal:  J Immunol Methods       Date:  1987-12-24       Impact factor: 2.303

2.  A simple and improved method to generate human hybridomas.

Authors:  T Kudo; H Saeki; T Tachibana
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

3.  Generation and immunohistological characterization of human monoclonal antibodies to mammary carcinoma cells.

Authors:  A Imam; M M Drushella; C R Taylor; Z A Tökés
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

4.  A human monoclonal antibody directed to blood group i antigen: heterohybridoma between human lymphocytes from regional lymph nodes of a lung cancer patient and mouse myeloma.

Authors:  S Hirohashi; H Clausen; E Nudelman; H Inoue; Y Shimosato; S Hakomori
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

5.  The production of monoclonal antibodies from human lymphocytes.

Authors:  D Kozbor; J C Roder
Journal:  Immunol Today       Date:  1983-03

6.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

Authors:  R F Irie; L L Sze; R E Saxton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.

Authors:  M R Posner; D J Santos; H S Elboim; M B Tumber; A R Frackelton
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

8.  Characterization of a human monoclonal antibody with broad reactivity to malignant tumor cells.

Authors:  H Saito; K Uchiyama; I Nakamura; H Hiraoka; Y Yamaguchi; M Taniguchi
Journal:  J Natl Cancer Inst       Date:  1988-07-20       Impact factor: 13.506

9.  Human monoclonal antibody (HMST-1) against lacto-series type 1 chain and expression of the chain in uterine endometrial cancers.

Authors:  S Nozawa; S Narisawa; K Kojima; M Sakayori; R Iizuka; H Mochizuki; T Yamauchi; M Iwamori; Y Nagai
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

10.  Human monoclonal antibody detects a cell surface antigen expressed on hematopoietic malignant cells of lymphoid lineage.

Authors:  T Iizasa; Y Yamaguchi; M Tagawa; T Fujisawa; H Saito; H Kondo; Y Matsuo; J Minowada; M Taniguchi
Journal:  Jpn J Cancer Res       Date:  1991-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.